Inhibition of BMI-1 expression increases the sensitivity to doxorubicin in human hepatocellular carcinoma cells
LI Min;SUN Hong-cheng;XUE Peng;HONG Yan;TIAN Ling;Laboratory Center;First People’s Hospital;Shanghai Jiao Tong University;Department of General Surgery;First People’s Hospital;Shanghai Jiao Tong University;Cancer Center;First People’s Hospital;Shanghai Jiao Tong University;

..............page:237-245

Effect of heat shock protein 70 inhibitor PES on NF-κB signal pathway of human gastric cancer BGC cells
ZHOU Qiao;GUO Wei;LONG Cong;ZHOU Heng;SUN Xiao-ping;Department of Pathogen Biology;Wuhan University School of Basic Medical Sciences;Department of Pathology and Pathophysiology;Wuhan University School of Basic Medical Sciences;Key Laboratory of National Virology;Wuhan University;

..............page:246-252

Cbl-b gene silencing enhances the ability of T lymphocytes to kill the mouse breast cancer cells
HAN Min-qiang;YANG Li-xian;ZHANG Xiao-dan;KONG Xiang-shun;Department of Oncology;Xingtai People’s Hospital;Hebei Medical University;

..............page:253-259+267

Oridonin in combination with celecoxib inhibits the proliferation and apoptosis of human osteosarcoma MG-63 cells in vitro
LIANG Fu-dong;DI Shu-fang;CHANG Yun-feng;LI Hong-wei;WANG Shuan-ke;Department of Orthopedics;Second Hospital of Lanzhou University;Gansu Provincial Key Laboratory of Osteoarticular diseases;

..............page:260-267

Regulation of expression of nestin in osteosarcoma MG63 cells induced by rapamycin and its mechanism
LIU Yu-dong;LI Fan;KAN Wu-sheng;XU Jian;LI Ming-jing;Department of Orthopedics;Wuhan Puai Hospital;

..............page:268-275

Inhibitory effect of BRAF^V600E gene silencing on proliferation of papillary thyroid cancer cells
WANG Hong-peng;ZHOU Xiao-hong;LI Zhen-hua;ZHANG Yu-lian;WU Jian;HE Yun;Department of Head and Neck Surgery;Chongqing Cancer Hospital;

..............page:276-282

Effects of RNA inter ference targeting Semaphorin 4D on proliferation, cell cycle and migration of human breast cancer cells
CHEN Wu-gui;SHEN Wei-wei;HU Xu;ZHUO Yun-yun;MAO De-ju;CHU Tong-wei;Department of Orthopedics;Second Affiliated Hospital;Third Military Medical University;

..............page:283-291

huan ying ding yue 2015 nian zhong liu za zhi

..............page:291

Clinicopathological characteristics and prognosis of 1006 Uygur and Han patients with different molecular subtypes of breast cancer
QIU Xiu-juan;CHENG Fang;LIU Ying;Department of Very Important Person;Tumor Hospital Ai liated to Xinjiang Medical University;

..............page:292-300

zhong liu za zhi tou gao shuo ming

..............page:300

Clinicopathological characteristics and prognosis of gastric remnant cancer
TIAN Lei;XIAO Xiu-ying;YE Ming;Department of Radiation Oncology;Renji Hospital;School of Medicine;Shanghai Jiao Tong University;Department of Oncology;Renji Hospital;School of Medicine;Shanghai Jiao Tong University;

..............page:301-311

Effect of pathological fracture on the prognosis of patients with limb osteosarcoma: a Meta-analysis
TIAN Cong;WANG Jiong-yi;LIU Feng;WANG Mei-ling;JIANG Bin;Department of Oncology;Shanghai Third People’s Hospital;School of Medicine;Shanghai Jiao Tong University;

..............page:312-321

Short-term therapeutic effect of recombinant human endostatin combined with chemotherapy for advanced gastric cancer: a Meta-analysis
SU Hang;HU Bing;JI Chu-shu;HE Yi-fu;HAN Xing-hua;Lü Ya-jing;Department of Medical Oncology;Provincial Hospital Affiliated to Anhui Medical University;

..............page:322-332

Neutrophil-to-lymphocyte ratio as a prognostic factor in patients with castration-resistant prostate cancer treated with docetaxel-based chemotherapy
ZHANG Jiao;WANG Hai-tao;YANG Qing;DU Jun;JIA Wei-ying;ZHANG Peng-yu;Department of Interventional Therapy;Tianjin Medical University Cancer Institute and Hospital;National Clinical Research Center for Cancer;Tianjin Key Laboratory of Cancer Prevention and Therapy;Department of Urologic Oncology;Tianjin Medical University Cancer Institute and Hospital;Department of Laboratory;Tianjin Medical University Cancer Institute and Hospital;

..............page:333-339

zhong liu za zhi zi 2015 nian qi dui suo you lai gao mian shou shen gao fei de tong zhi

..............page:339

The association of efficacy of TACE and prognosis with MDR1 gene expression in patients with hepatic cancer
WU Zhao-yu;GUO Ying-xing;LEI Jin-yuan;YU Hai-dong;Department of Interventional Radiology;Affiliated Hospital of Qinghai University;

..............page:340-345

From basic studies to clinical application: advances in novel oncogene ATAD2 and tumors
DING Qian-shan;WANG Qi;SUN Rong-ze;SHEN Shi-qiang;Department of Hepatobiliary Surgery and Enteroscopy;Renmin Hospital of Wuhan University/Hubei Provincial People’s Hospital;Cancer Center;;Renmin Hospital of Wuhan University/Hubei Provincial People’s Hospital;

..............page:346-350

The role of intestinal flora in the occurrence and development of colorectal cancer and its mechanism
LIANG Qian;HONG Jie;FANG Jing-yuan;Department of Gastroenterology;Renji Hospital;School of Medicine;Shanghai Jiao Tong University;Shanghai Institute of Digestive Disease;

..............page:351-355

The advances in research on FOXO in ovarian cancer
ZHANG Nan;WANG Yu;Department of Gynaecology and Obstetrics;Renji Hospital;Shanghai Jiao Tong University;

..............page:356-360